Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06649097 · ClinicalTrials.gov registry record
Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System
A clinical trial of Intracranial Hemorrhage and Ventriculitis, sponsored by Christopher P Kellner.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT06649097 is a study of Intracranial Hemorrhage and Ventriculitis that is actively recruiting participants, run by Christopher P Kellner. The registered enrollment target is 250 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06649097, a study of Intracranial Hemorrhage and Ventriculitis, is actively recruiting participants, sponsored by Christopher P Kellner.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a multi-center prospective cohort, controlled, phase 4 post-market registry evaluating the efficacy and radiographic outcomes associated with the use of the IRRAflow® Active Fluid Exchange System compared to standard of care external ventricular drains.
Conditions Studied
Interventions
- DEVICE IRRAflow® CNS (Active Fluid Exchange) System
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-09-25 |
| Est. Completion | 2031-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06649097
The ClinicalTrials.gov registry entry for NCT06649097 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher P Kellner, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Intracranial Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which IRRAflow® CNS (Active Fluid Exchange) System is the first listed.
NCT06649097 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06649097 about?
NCT06649097 is a clinical study titled "Clearance of Intracranial Blood Products by Continuous Irrigation With the IRRAflow System". The study is a multi-center prospective cohort, controlled, phase 4 post-market registry evaluating the efficacy and radiographic outcomes associated with the use of the IRRAflow® Active Fluid Exchange System compared to standard of care external ventricular drains.
What is the current status of trial NCT06649097?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-09-25. Estimated completion is 2031-07.
What conditions does trial NCT06649097 study?
This clinical trial studies the following conditions: Intracranial Hemorrhage, Ventriculitis, Intracranial Abscess.
What interventions are being tested in trial NCT06649097?
The interventions under investigation include: IRRAflow® CNS (Active Fluid Exchange) System (DEVICE).
Who is sponsoring clinical trial NCT06649097?
This trial is sponsored by Christopher P Kellner, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06649097 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.